Publications by authors named "Johanna Tischer"

87Publications

[Correction: Onko-Nexus: A Bavarian "Caretaker Project" to Overcome the Interface Outpatient/Hospitalized Division - Three-Year Results].

Gesundheitswesen 2020 Aug 3. Epub 2020 Aug 3.

Medizinische Klinik und Poliklinik III, Ludwig-Maximilians-Universität München, München.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-1228-1722DOI Listing
August 2020

Timing of Post-Transplantation Cyclophosphamide Administration in Haploidentical Transplantation: A Comparative Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Biol Blood Marrow Transplant 2020 Oct 6;26(10):1915-1922. Epub 2020 Jul 6.

Hematology Department, Service d'Hématologie et Thérapie Cellulaire, Hôpital Saint Antoine, Paris, France; Sorbonne Universités, INSERM, Centre de Recherche Saint-Antoine, UPMC Univ Paris 06, Paris, France; European Society for Blood and Marrow Transplantation, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2020.06.026DOI Listing
October 2020

WT1, PRAME, and PR3 mRNA Expression in Acute Myeloid Leukemia (AML).

J Immunother 2020 Jul/Aug;43(6):204-215

Helmholtz Center Munich, German Research Center for Environmental Health.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000322DOI Listing
June 2020

[Onko-Nexus: A Bavarian "Caretaker Project" to Overcome the Interface Outpatient/Hospitalized Division - Three-Year Results].

Gesundheitswesen 2020 Apr 7. Epub 2020 Apr 7.

Medizinische Klinik und Poliklinik III, Ludwig-Maximilians-Universität München, München.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-1128-038DOI Listing
April 2020

Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS.

Am J Hematol 2018 12 2;93(12):1524-1531. Epub 2018 Oct 2.

Department of Medicine III, Hematopoietic Stem Cell Transplantation, University Hospital of Munich-Grosshadern, Ludwig-Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.25281DOI Listing
December 2018

Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B.

PLoS Pathog 2018 04 26;14(4):e1006991. Epub 2018 Apr 26.

DZIF Research Group "Host Control of Viral Latency and Reactivation" (HOCOVLAR), Research Unit Gene Vectors, Helmholtz Zentrum München, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.ppat.1006991DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919459PMC
April 2018

Allogeneic stem cell transplantation in adolescents and young adults with primary immunodeficiencies.

J Allergy Clin Immunol Pract 2018 Jan - Feb;6(1):298-301.e2. Epub 2017 Sep 22.

Pediatric Hematology/Oncology/Immunology, Dr von Hauner University Children's Hospital, Ludwig-Maximillians-University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaip.2017.07.045DOI Listing
October 2019

Characteristics and Outcome of Patients After Allogeneic Hematopoietic Stem Cell Transplantation Treated With Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome.

Crit Care Med 2017 May;45(5):e500-e507

1Department of Medicine I, Intensive Care Unit 13i2, Medical University of Vienna, Vienna, Austria. 2Department of Hematology, Hemostaseology, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany. 3Department of Cardiovascular Medicine, University Hospital Muenster, Muenster, Germany. 4Department of Medicine III, Intensive Care Unit I3, LMU Munich, Campus Großhadern, Munich, Germany. 5Medical Intensive Care Unit, Institute of Cardiometabolism and Nutrition, Hôpital de la Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Université Pierre et Marie Curie, Paris, France. 6Department of Internal Medicine I, University of Cologne, Cologne, Germany. 7Department of Bone Marrow Transplantation, University Hospital Essen, West German Cancer Center, University of Duisburg-Essen, Essen, Germany. 8Department of Intensive Care, Hopital Erasme, Université Libre de Bruxelles, Brussels, Belgium. 9Medical Intensive Care Unit, Saint-Louis Teaching Hospital, Paris, France. 10Service de Pneumologie et Réanimation Médicale, Groupe Hospitalier Pitié Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France. 11Sorbonne Universités, UPMC Univ Paris 06, INSERM, UMRS1158 Neurophysiologie respiratoire expérimentale et clinique, Paris, France. 12Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 13Department of Anaesthesiology, Oslo University Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000002293DOI Listing
May 2017

Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.

J Clin Virol 2016 09 10;82:33-40. Epub 2016 Jul 10.

Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Department of Internal Medicine III, Hematopoietic Stem Cell Transplantation, Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcv.2016.07.002DOI Listing
September 2016

Increase of PD-L1 expressing B-precursor ALL cells in a patient resistant to the CD19/CD3-bispecific T cell engager antibody blinatumomab.

J Hematol Oncol 2015 Oct 8;8:111. Epub 2015 Oct 8.

Department of Internal Medicine III, Ludwig-Maximilians-Universität (LMU), Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-015-0213-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599591PMC
October 2015

Profiles of activation, differentiation-markers, or β-integrins on T cells contribute to predict T cells' antileukemic responses after stimulation with leukemia-derived dendritic cells.

J Immunother 2014 Jul-Aug;37(6):331-47

*Department for Hematopoetic Cell Transplantations, University Hospital of Munich †Helmholtz Center Munich (German Research Center for Environmental Health and Clinical Cooperative Group Hematopoetic Cell-Transplantation), Munich ‡Department for Hematology and Oncology, Municipal Hospital, Oldenburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000037DOI Listing
April 2015

Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of Heterozygosity.

Bone Marrow Res 2014 3;2014:541345. Epub 2014 Apr 3.

Laboratory of Immunogenetics, Department of Transfusion Medicine, Cell Therapeutic Agents and Hemostaseology, University Hospital of Munich, Ludwig Maximilians University, Max-Lebsche-Platz 32, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2014/541345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996364PMC
May 2014

CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.

Immunobiology 2014 Apr 27;219(4):247-60. Epub 2013 Oct 27.

Helmholtz Center Munich (German Research Center for Environmental Health and Clinical Cooperative Group Hematopoetic Cell-Transplantation), 81377 Munich, Germany; University Hospital of Munich, Department for Hematopoetic Cell Transplantation, Med. Dept. 3, 81377 Munich, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imbio.2013.10.008DOI Listing
April 2014

Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia.

Ann Hematol 2013 Oct 9;92(10):1379-88. Epub 2013 Aug 9.

Department of Medicine III, Hematopoietic stem cell transplantation, Ludwig-Maximilians University of Munich, Campus Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1862-6DOI Listing
October 2013

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.

J Clin Oncol 2013 Sep 5;31(26):3259-71. Epub 2013 Aug 5.

Maximilian Christopeit and Oliver Kuss, University of Halle, Halle (Saale); Jürgen Finke and Hartmut Bertz, University Hospital Freiburg, Freiburg; Ulrike Bacher and Nicolaus Kröger, Bone Marrow Transplantation Centre, University Hospital Hamburg-Eppendorf, Hamburg; Ulrike Bacher, Munich Leukaemia Laboratory; Johanna Tischer, Ludwig Maximilian University Hospital; Hans-Jochem Kolb, Technical University Hospital, Munich; Christoph Schmid, Augsburg Medical Hospital, Ludwig Maximilian University of Munich, Augsburg; Dietrich Wilhelm Beelen, University Hospital Essen, Essen; Martin Bornhäuser, University Hospital Dresden, Dresden; Rainer Schwerdtfeger, Deutsche Klinik für Diagnostik, Wiesbaden; Wolfgang Andreas Bethge, University Hospital Tübingen, Tübingen; Nadezda Basara and Dietger Niederwieser, University Hospital Leipzig, Leipzig; Martin Gramatzki, University Hospital Kiel, Kiel; Lutz Uharek, Charité-Campus B. Franklin, University Hospital Berlin, Berlin; Ralf G. Meyer, University Medical Center Mainz, Mainz; Donald Bunjes, University Hospital Ulm; Hubert Schrezenmeier, Deutsches Register für Stammzelltransplantation and Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University of Ulm, Ulm; Christof Scheid, University Hospital Cologne, Cologne; and Hans Martin, University Hospital Frankfurt, Frankfurt, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.7961DOI Listing
September 2013

Anti-leukaemic activity of a novel haploidentical-transplantation approach employing unmanipulated bone marrow followed by CD6-depleted peripheral blood stem cells in children with refractory/relapsed acute leukaemia.

Br J Haematol 2013 Sep 6;162(6):802-7. Epub 2013 Jul 6.

Clinic of Paediatric Oncology, Haematology and Clinical Immunology, Centre for Child and Adolescent Health, Medical Faculty, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12455DOI Listing
September 2013

Antileukemic T-cell responses can be predicted by the composition of specific regulatory T-cell subpopulations.

J Immunother 2013 May;36(4):223-37

Department for Hematopoietic Cell Transplantation, Medicine Department 3, University Hospital of Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e31829180e7DOI Listing
May 2013

Mortality of patients with hematological malignancy after admission to the intensive care unit.

Onkologie 2012 18;35(10):556-61. Epub 2012 Sep 18.

Medical Department II, Intensive Care Unit, Ludwig Maximilian University of Munich, Campus Großhadern, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000342672DOI Listing
March 2013

Isotopic response, Köbner phenomenon and Renbök phenomenon following herpes zoster.

J Dermatol 2011 Nov 20;38(11):1058-61. Epub 2011 Sep 20.

Department of Dermatology and Allergy, Bone Marrow Transplantation Unit, Ludwig Maximilian University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1346-8138.2011.01329.xDOI Listing
November 2011

The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.

J Immunother 2010 Jun;33(5):523-37

*Department for Hematopoetic Transplantations, University of Munich, Munich daggerDepartment for Hematology, Municipal Hospital Augsburg, Augsburg section signHelmholtz Center, Munich double daggerMunicipal Hospital Oldenburg, Germany.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00002371-201006000-000
Publisher Site
http://dx.doi.org/10.1097/CJI.0b013e3181d87ffdDOI Listing
June 2010

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.

Blood 2010 Apr 26;115(14):2960-70. Epub 2010 Jan 26.

Clinical Cooperation Group Molecular Oncology, Helmholtz Zentrum München and Ludwig-Maximilians-Universität, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-08-236356DOI Listing
April 2010

A clinical cohort trial of antifungal combination therapy: efficacy and toxicity in haematological cancer patients.

Ann Hematol 2008 Nov 19;87(11):915-22. Epub 2008 Jul 19.

Department of Haematology/Oncology, University Hospital Grosshadern, Ludwig-Maximilians-University Munich, Marchioninistrasse 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-008-0534-4DOI Listing
November 2008

A comparison of donor lymphocyte infusions or imatinib mesylate for patients with chronic myelogenous leukemia who have relapsed after allogeneic stem cell transplantation.

Haematologica 2006 May 19;91(5):663-6. Epub 2006 Apr 19.

Department of Internal Medicine III, University of Munich, Klinikum Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
May 2006

Allogeneic stem cell transplantation as a new treatment option for patients with severe Bernard-Soulier Syndrome.

Thromb Haemost 2006 Jan;95(1):190-1

Department of Internal Medicine 111, University Hospital Grosshadern, Munich, Germany.

View Article

Download full-text PDF

Source
January 2006

DLI: where are we know?

Hematology 2005 ;10 Suppl 1:115-6

Haematopoietic Cell Transplantation, Dept of Medicine III, University of Munich & GSF-National Research Centre for Environment and Health, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10245330512331390122DOI Listing
June 2006

Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.

J Clin Oncol 2005 Aug;23(24):5675-87

José Carreras Unit for Hematopoietic Stem Cell Transplantation, Department of Medicine III, Ludwig-Maximilians-University Hospital, Marchioninistr 15, 81379 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.07.061DOI Listing
August 2005

In-vivo generation of leukaemia-derived dendritic cells.

Best Pract Res Clin Haematol 2004 Sep;17(3):439-51

Clinical Cooperative Group Haematopoietic Cell Transplantation, Department of Medicine III, University of Munich, GSF-National Research Centre for Environment and Health, Marchioninistr. 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2004.06.004DOI Listing
September 2004